Gene signature predictor of dose-response to prostate radiation: Validation of PORTOS in phase III trials.
Journal Articles
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
publication date
has subject area
published in
Research
keywords
-
32 Biomedical and Clinical Sciences
-
3202 Clinical Sciences
-
3211 Oncology and Carcinogenesis
-
4.1 Discovery and preclinical testing of markers and technologies
-
Aging
-
Cancer
-
Clinical Research
-
Clinical Trials and Supportive Activities
-
Genetics
-
Precision Medicine
-
Prostate Cancer
-
Radiation Oncology
-
Urologic Diseases
Identity
Digital Object Identifier (DOI)
Additional Document Info
start page
end page
volume
issue